Trade Teladoc Health, Inc. - TDOC CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.13 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Teladoc Health Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Prev. Close* | 18.08 |
Open* | 17.94 |
1-Year Change* | -36.83% |
Day's Range* | 17.94 - 18.94 |
52 wk Range | 15.02-34.36 |
Average Volume (10 days) | 4.11M |
Average Volume (3 months) | 100.18M |
Market Cap | 2.80B |
P/E Ratio | -100.00K |
Shares Outstanding | 165.56M |
Revenue | 2.58B |
EPS | -24.66 |
Dividend (Yield %) | N/A |
Beta | 1.09 |
Next Earnings Date | Feb 20, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 30, 2023 | 18.08 | -0.31 | -1.69% | 18.39 | 18.54 | 17.87 |
Nov 29, 2023 | 18.32 | 0.03 | 0.16% | 18.29 | 19.25 | 18.26 |
Nov 28, 2023 | 18.03 | 1.02 | 6.00% | 17.01 | 18.16 | 16.89 |
Nov 27, 2023 | 17.15 | 0.00 | 0.00% | 17.15 | 17.21 | 16.86 |
Nov 24, 2023 | 17.29 | 0.17 | 0.99% | 17.12 | 17.40 | 17.05 |
Nov 22, 2023 | 16.98 | -0.08 | -0.47% | 17.06 | 17.29 | 16.86 |
Nov 21, 2023 | 16.86 | -0.31 | -1.81% | 17.17 | 17.20 | 16.78 |
Nov 20, 2023 | 17.41 | 0.32 | 1.87% | 17.09 | 17.66 | 16.90 |
Nov 17, 2023 | 17.11 | 0.15 | 0.88% | 16.96 | 17.12 | 16.74 |
Nov 16, 2023 | 16.87 | -0.34 | -1.98% | 17.21 | 17.37 | 16.59 |
Nov 15, 2023 | 17.47 | 0.42 | 2.46% | 17.05 | 17.75 | 17.05 |
Nov 14, 2023 | 16.99 | 0.78 | 4.81% | 16.21 | 17.12 | 16.21 |
Nov 13, 2023 | 15.58 | -0.25 | -1.58% | 15.83 | 16.00 | 15.57 |
Nov 10, 2023 | 15.88 | 0.41 | 2.65% | 15.47 | 15.93 | 15.42 |
Nov 9, 2023 | 15.60 | -0.61 | -3.76% | 16.21 | 16.43 | 15.53 |
Nov 8, 2023 | 16.13 | -0.43 | -2.60% | 16.56 | 16.78 | 16.13 |
Nov 7, 2023 | 16.89 | 0.13 | 0.78% | 16.76 | 17.04 | 16.43 |
Nov 6, 2023 | 16.74 | -0.62 | -3.57% | 17.36 | 17.41 | 16.41 |
Nov 3, 2023 | 17.33 | 0.11 | 0.64% | 17.22 | 17.91 | 17.08 |
Nov 2, 2023 | 16.87 | -0.19 | -1.11% | 17.06 | 17.17 | 16.51 |
Teladoc Health, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, February 20, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q4 2023 Teladoc Health Inc Earnings Release Q4 2023 Teladoc Health Inc Earnings ReleaseForecast -Previous - |
Wednesday, April 24, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q1 2024 Teladoc Health Inc Earnings Release Q1 2024 Teladoc Health Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 2406.84 | 2032.71 | 1093.96 | 553.307 | 417.907 |
Revenue | 2406.84 | 2032.71 | 1093.96 | 553.307 | 417.907 |
Cost of Revenue, Total | 743.987 | 650.258 | 390.829 | 184.465 | 128.735 |
Gross Profit | 1662.85 | 1382.45 | 703.133 | 368.842 | 289.172 |
Total Operating Expense | 16060.1 | 2342.09 | 1609.46 | 633.749 | 488.761 |
Selling/General/Admin. Expenses, Total | 1300.56 | 1105.31 | 886.882 | 339.068 | 265.16 |
Research & Development | 333.629 | 311.884 | 164.941 | 64.644 | 54.373 |
Depreciation / Amortization | 256.027 | 204.239 | 69.495 | 38.952 | 35.602 |
Unusual Expense (Income) | 13425.8 | 70.391 | 97.313 | 6.62 | 4.891 |
Operating Income | -13653.2 | -309.379 | -515.498 | -80.442 | -70.854 |
Interest Income (Expense), Net Non-Operating | -9.27 | -80.365 | -60.495 | -29.013 | -26.112 |
Net Income Before Taxes | -13663.3 | -384.656 | -575.993 | -109.455 | -96.966 |
Net Income After Taxes | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Net Income Before Extra. Items | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Net Income | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Income Available to Common Excl. Extra. Items | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Income Available to Common Incl. Extra. Items | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Diluted Net Income | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Diluted Weighted Average Shares | 161.457 | 156.939 | 90.5092 | 71.8445 | 65.8449 |
Diluted EPS Excluding Extraordinary Items | -84.6016 | -2.73223 | -5.36007 | -1.37608 | -1.47443 |
Diluted Normalized EPS | -30.5513 | -2.44069 | -4.66121 | -1.31619 | -1.42615 |
Total Extraordinary Items | |||||
Other, Net | -0.859 | 5.088 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total revenue | 660.238 | 652.406 | 629.244 | 637.709 | 611.402 |
Revenue | 660.238 | 652.406 | 629.244 | 637.709 | 611.402 |
Cost of Revenue, Total | 185.96 | 190.54 | 190.107 | 188.873 | 185.619 |
Gross Profit | 474.278 | 461.866 | 439.137 | 448.836 | 425.783 |
Total Operating Expense | 724.963 | 724.051 | 706.346 | 4453.26 | 683.132 |
Selling/General/Admin. Expenses, Total | 354.177 | 358.127 | 345.425 | 324.243 | 346.096 |
Research & Development | 84.289 | 87.309 | 86.985 | 77.576 | 87.815 |
Depreciation / Amortization | 94.302 | 75.465 | 69.783 | 75.715 | 62.008 |
Unusual Expense (Income) | 6.235 | 12.61 | 14.046 | 3786.85 | 1.594 |
Operating Income | -64.725 | -71.645 | -77.102 | -3815.55 | -71.73 |
Interest Income (Expense), Net Non-Operating | 6.96 | 5.723 | 3.648 | 1.893 | -1.346 |
Other, Net | -1.792 | -0.207 | 4.907 | 1.748 | -1.571 |
Net Income Before Taxes | -59.557 | -66.129 | -68.547 | -3811.91 | -74.647 |
Net Income After Taxes | -57.073 | -65.177 | -69.228 | -3810.07 | -73.476 |
Net Income Before Extra. Items | -57.073 | -65.177 | -69.228 | -3810.07 | -73.476 |
Net Income | -57.073 | -65.177 | -69.228 | -3810.07 | -73.476 |
Income Available to Common Excl. Extra. Items | -57.073 | -65.177 | -69.228 | -3810.07 | -73.476 |
Income Available to Common Incl. Extra. Items | -57.073 | -65.177 | -69.228 | -3810.07 | -73.476 |
Diluted Net Income | -57.073 | -65.177 | -69.228 | -3810.07 | -73.476 |
Diluted Weighted Average Shares | 165.119 | 164.171 | 162.923 | 162.177 | 161.728 |
Diluted EPS Excluding Extraordinary Items | -0.34565 | -0.39701 | -0.42491 | -23.4932 | -0.45432 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.3211 | -0.34708 | -0.36887 | -8.31568 | -0.44791 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 1315.39 | 1225.44 | 1059.61 | 588.002 | 532.736 |
Cash and Short Term Investments | 918.182 | 896.017 | 786.569 | 517.064 | 478.534 |
Cash & Equivalents | 918.182 | 893.48 | 733.324 | 514.353 | 423.989 |
Short Term Investments | 0 | 2.537 | 53.245 | 2.711 | 54.545 |
Total Receivables, Net | 235.645 | 168.956 | 169.281 | 56.948 | 43.571 |
Accounts Receivable - Trade, Net | 210.554 | 168.956 | 169.281 | 56.948 | 43.571 |
Prepaid Expenses | 63.159 | 87.387 | 47.259 | 13.99 | 10.631 |
Total Assets | 4345.35 | 17734.6 | 17755.3 | 1602.83 | 1528.88 |
Property/Plant/Equipment, Total - Net | 71.472 | 74.014 | 75.198 | 36.748 | 10.148 |
Property/Plant/Equipment, Total - Gross | 119.184 | 108.144 | 97.163 | 52.51 | 22.431 |
Accumulated Depreciation, Total | -47.712 | -34.13 | -21.965 | -15.762 | -12.283 |
Goodwill, Net | 1073.19 | 14504.2 | 14581.3 | 746.079 | 737.197 |
Intangibles, Net | 1836.77 | 1910.28 | 2020.86 | 225.453 | 247.394 |
Other Long Term Assets, Total | 48.54 | 20.703 | 18.357 | 6.545 | 1.401 |
Total Current Liabilities | 399.769 | 331.013 | 332.649 | 90.181 | 62.439 |
Accounts Payable | 47.69 | 47.257 | 46.03 | 9.075 | 7.769 |
Accrued Expenses | 193.44 | 162.009 | 156.066 | 57.785 | 41.212 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 11.375 | 13.313 | 56.013 | ||
Other Current Liabilities, Total | 147.264 | 108.434 | 74.54 | 23.321 | 13.458 |
Total Liabilities | 2037.61 | 1688.85 | 1871.48 | 588.802 | 515.757 |
Total Long Term Debt | 1543.37 | 1234.96 | 1389.52 | 440.41 | 414.683 |
Long Term Debt | 1543.37 | 1234.96 | 1389.52 | 440.41 | 414.683 |
Deferred Income Tax | 50.939 | 75.777 | 102.103 | 21.678 | 32.444 |
Other Liabilities, Total | 43.532 | 47.099 | 47.207 | 36.533 | 6.191 |
Total Equity | 2307.75 | 16045.8 | 15883.8 | 1014.03 | 1013.12 |
Common Stock | 0.163 | 0.16 | 0.15 | 0.073 | 0.07 |
Additional Paid-In Capital | 17358.6 | 17473.3 | 16857.8 | 1538.72 | 1434.78 |
Retained Earnings (Accumulated Deficit) | -15008.3 | -1421.45 | -992.661 | -507.525 | -408.661 |
Other Equity, Total | -42.776 | -6.285 | 18.518 | -17.239 | -13.07 |
Total Liabilities & Shareholders’ Equity | 4345.35 | 17734.6 | 17755.3 | 1602.83 | 1528.88 |
Total Common Shares Outstanding | 162.84 | 160.469 | 150.281 | 72.7619 | 70.5163 |
Total Inventory | 56.342 | 73.079 | 56.498 | ||
Other Current Assets, Total | 42.06 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1387.09 | 1320.96 | 1286.71 | 1315.39 | 1287.59 |
Cash and Short Term Investments | 1030.53 | 958.695 | 888.579 | 918.182 | 899.631 |
Cash & Equivalents | 1030.53 | 958.695 | 888.579 | 918.182 | 899.631 |
Short Term Investments | 0 | 0 | |||
Total Receivables, Net | 218.741 | 227.444 | 241.08 | 210.554 | 201.701 |
Accounts Receivable - Trade, Net | 205.866 | 215.181 | 215.981 | 210.554 | 201.701 |
Total Inventory | 35.916 | 34.054 | 45.801 | 56.342 | 59.344 |
Prepaid Expenses | 62.248 | 62.103 | 77.526 | 130.31 | 126.912 |
Total Assets | 4327.97 | 4316.4 | 4309.15 | 4345.35 | 8103.96 |
Property/Plant/Equipment, Total - Net | 64.938 | 65.216 | 69.309 | 71.472 | 72.457 |
Goodwill, Net | 1073.19 | 1073.19 | 1073.19 | 1073.19 | 4846 |
Intangibles, Net | 1728.3 | 1784.1 | 1815.95 | 1836.77 | 1854.26 |
Other Long Term Assets, Total | 74.452 | 72.93 | 63.993 | 48.54 | 43.656 |
Total Current Liabilities | 402.64 | 383.394 | 381.344 | 399.769 | 411.401 |
Accounts Payable | 25.998 | 16.071 | 38.625 | 47.69 | 70.783 |
Accrued Expenses | 224.739 | 208.116 | 192.872 | 193.44 | 202.633 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 11.247 | 11.375 | 10.086 | ||
Other Current Liabilities, Total | 151.903 | 159.207 | 138.6 | 147.264 | 127.899 |
Total Liabilities | 2033.92 | 2021.26 | 2017.92 | 2037.61 | 2051.3 |
Total Long Term Debt | 1537.83 | 1536.98 | 1544.17 | 1543.37 | 1542.3 |
Long Term Debt | 1537.83 | 1536.98 | 1544.17 | 1543.37 | 1542.3 |
Deferred Income Tax | 44.252 | 48.097 | 50.613 | 50.939 | 51.742 |
Other Liabilities, Total | 49.198 | 52.789 | 41.793 | 43.532 | 45.858 |
Total Equity | 2294.05 | 2295.14 | 2291.23 | 2307.75 | 6052.66 |
Common Stock | 0.166 | 0.165 | 0.164 | 0.163 | 0.162 |
Additional Paid-In Capital | 17535.2 | 17476.5 | 17409.6 | 17358.6 | 17300 |
Retained Earnings (Accumulated Deficit) | -15199.8 | -15142.7 | -15077.5 | -15008.3 | -11198.2 |
Other Equity, Total | -41.52 | -38.78 | -40.997 | -42.776 | -49.266 |
Total Liabilities & Shareholders’ Equity | 4327.97 | 4316.4 | 4309.15 | 4345.35 | 8103.96 |
Total Common Shares Outstanding | 165.557 | 164.877 | 163.919 | 162.84 | 162.196 |
Other Current Assets, Total | 39.659 | 38.668 | 33.721 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -13659.5 | -428.793 | -485.136 | -98.864 | -97.084 |
Cash From Operating Activities | 189.292 | 193.99 | -53.511 | 29.869 | -4.86 |
Cash From Operating Activities | 258.886 | 204.239 | 71.192 | 44.952 | 35.602 |
Deferred Taxes | -7.84 | 41.8 | -90.158 | -10.868 | -2.247 |
Non-Cash Items | 13658.7 | 427.068 | 541.074 | 94.805 | 59.999 |
Cash Interest Paid | 17.361 | 16.43 | 14.89 | 12.224 | 10.303 |
Changes in Working Capital | -60.971 | -50.324 | -90.483 | -0.156 | -1.13 |
Cash From Investing Activities | -167.743 | -72.981 | -590.975 | 25.013 | -257.496 |
Capital Expenditures | -172.764 | -63.934 | -26.042 | -10.9 | -8.407 |
Other Investing Cash Flow Items, Total | 5.021 | -9.047 | -564.933 | 35.913 | -249.089 |
Cash From Financing Activities | 6.497 | 40.947 | 859.136 | 35.094 | 645.612 |
Financing Cash Flow Items | -2.741 | -0.73 | -36.703 | -1.569 | 1.721 |
Issuance (Retirement) of Stock, Net | 12.385 | 42.591 | 59.036 | 36.663 | 364.729 |
Issuance (Retirement) of Debt, Net | -3.147 | -0.914 | 836.803 | 0 | 279.162 |
Foreign Exchange Effects | -3.344 | -1.8 | 4.321 | 0.388 | -2.084 |
Net Change in Cash | 24.702 | 160.156 | 218.971 | 90.364 | 381.172 |
Cash Taxes Paid | 2.512 | 3.974 | 1.324 | 1.31 | 0.441 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -69.228 | -13659.5 | -9849.46 | -9775.98 | -6674.52 |
Cash From Operating Activities | 13.156 | 189.292 | 123.743 | 60.722 | -31.747 |
Cash From Operating Activities | 70.464 | 258.886 | 182.497 | 119.79 | 59.703 |
Deferred Taxes | -0.355 | -7.84 | -5.942 | -2.528 | -2.319 |
Non-Cash Items | 55.451 | 13658.7 | 9821.4 | 9755.49 | 6669.03 |
Cash Taxes Paid | 0.346 | 2.512 | 0.901 | 0.564 | 0.261 |
Cash Interest Paid | 0.194 | 17.361 | 8.688 | 8.673 | 0.007 |
Changes in Working Capital | -43.176 | -60.971 | -24.756 | -36.048 | -83.634 |
Cash From Investing Activities | -45.624 | -167.743 | -113.852 | -72.404 | -27.567 |
Capital Expenditures | -45.624 | -172.764 | -118.873 | -75.668 | -30.831 |
Other Investing Cash Flow Items, Total | 0 | 5.021 | 5.021 | 3.264 | 3.264 |
Cash From Financing Activities | 3.353 | 6.497 | 2.116 | 1.482 | 2.816 |
Financing Cash Flow Items | 0.499 | -2.741 | -2.253 | -2.794 | -2.76 |
Issuance (Retirement) of Stock, Net | 3.027 | 12.385 | 9.032 | 6.952 | 7.265 |
Issuance (Retirement) of Debt, Net | -0.173 | -3.147 | -4.663 | -2.676 | -1.689 |
Foreign Exchange Effects | -0.488 | -3.344 | -5.856 | -2.119 | -0.538 |
Net Change in Cash | -29.603 | 24.702 | 6.151 | -12.319 | -57.036 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
ARK Investment Management LLC | Investment Advisor | 12.2688 | 20311873 | -32228 | 2023-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 10.4371 | 17279450 | 1268630 | 2023-06-30 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 4.6435 | 7687646 | -181228 | 2023-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.4715 | 7402854 | -669382 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.1028 | 5136970 | 170726 | 2023-06-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.6624 | 4407819 | 1038319 | 2023-06-30 | HIGH |
Michigan Department of Treasury | Pension Fund | 1.9105 | 3163000 | -670000 | 2023-09-30 | |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.6921 | 2801351 | -792468 | 2023-06-30 | LOW |
Nikko Asset Management Americas, Inc. | Investment Advisor/Hedge Fund | 1.6632 | 2753556 | -27174 | 2022-12-31 | LOW |
First Trust Advisors L.P. | Investment Advisor | 1.4917 | 2469576 | 854434 | 2023-06-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.4214 | 2353278 | 127309 | 2023-06-30 | LOW |
Federated MDTA LLC | Investment Advisor/Hedge Fund | 1.3566 | 2245905 | -267620 | 2023-06-30 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 1.3185 | 2182947 | -3179155 | 2023-06-30 | HIGH |
Himension Capital (Singapore) Pte. Ltd | Investment Advisor | 1.305 | 2160507 | -82100 | 2023-06-30 | MED |
Baillie Gifford & Co. | Investment Advisor | 1.0731 | 1776578 | -3050303 | 2023-06-30 | LOW |
Balyasny Asset Management LP | Hedge Fund | 1.0304 | 1705844 | 1295092 | 2023-06-30 | HIGH |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.9389 | 1554448 | -297480 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8845 | 1464347 | 89223 | 2022-12-31 | LOW |
Credit Suisse Funds AG | Investment Advisor/Hedge Fund | 0.7518 | 1244679 | -33934 | 2023-06-30 | LOW |
AHL Partners LLP | Hedge Fund | 0.7042 | 1165901 | 261493 | 2023-06-30 | HIGH |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Teladoc Health, Inc. Company profile
Teladoc Health Inc provides virtual healthcare services on a business-to-business basis in the US and internationally. According to the company, it’s the largest telehealth platform in the US.
The company looks to provide fast, remotely accessible and affordable healthcare. Teladoc connects customers with over 1,100 board-certified physicians and behavioural health professionals, delivering on-demand healthcare via the internet on video or phone.
Teladoc Health serves numerous corporations, health plans, health systems and other entities. The company generates revenue via subscriptions and per visit fees.
The company provides point-of-care devices and solutions – Viewpoint Cart, TV Pro, Xpress Cart, Vantage and Vita – to hospitals for patient care and monitoring. Teladoc Health also offers its products and services under the brands Teladoc, InTouch Health, Livongo, BetterHelp, MedecinDirect and HealthiestYou.
Jason Gorevic has been the company’s chief executive since 2009. The company was initially known as Teladoc. It was renamed Teladoc Health in August 2018. Teladoc Health was incorporated in 2002. It’s headquartered in Purchase, New York.
Industry: | Telemedicine Services |
2 Manhattanville Rd Ste 203
PURCHASE
NEW YORK 10577-2118
US
Income Statement
- Annual
- Quarterly
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com